MorphoSys (MPSYF) Short Interest Ratio & Short Volume $73.27 0.00 (0.00%) (As of 11/21/2024) Add Compare Share Share Short Interest Stock AnalysisChartFinancialsSEC FilingsShort Interest MorphoSys Short Interest DataMorphoSys (MPSYF) has a short interest of 5,000 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 50.0, indicating that it would take 50.0 days of the average trading volume of 1,800 shares to cover all short positions.Current Short Interest5,000 sharesPrevious Short Interest5,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$366,350.00Short Interest Ratio50.0 Days to CoverLast Record DateOctober 15, 2024Today's Trading Volume0 sharesAverage Trading Volume1,800 sharesToday's Volume Vs. Average0% Short Selling MorphoSys? Sign up to receive the latest short interest report for MorphoSys and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMPSYF Short Interest Over TimeMPSYF Days to Cover Over TimeMPSYF Percentage of Float Shorted Over Time Ad Porter & CompanyI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. MorphoSys Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20245,000 shares $366,350.00 No ChangeN/A50 $73.27 9/30/20245,000 shares $366,350.00 -26.5%N/A0 $73.27 9/15/20246,800 shares $498,236.00 No ChangeN/A0 $73.27 8/31/20246,800 shares $498,236.00 No ChangeN/A0 $73.27 8/15/20246,800 shares $498,236.00 -77.3%N/A0 $73.27 7/31/202430,000 shares $2.20 million -3.2%N/A0 $73.27 Get the Latest News and Ratings for MPSYF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MorphoSys and its competitors with MarketBeat's FREE daily newsletter. 7/15/202431,000 shares $2.27 million -0.3%N/A44.3 $73.27 6/30/202431,100 shares $2.23 million -2.8%N/A311 $71.76 6/15/202432,000 shares $2.28 million -6.2%N/A0 $71.38 5/31/202434,100 shares $2.43 million -62.0%N/A0 $71.38 5/15/202489,700 shares $6.40 million -80.3%N/A0 $71.38 4/30/2024455,100 shares $32.49 million -42.5%N/A4551 $71.38 4/15/2024791,800 shares $56.52 million +0.9%N/A0 $71.38 3/31/2024784,400 shares $55.99 million +0.8%N/A461.4 $71.38 3/15/2024778,100 shares $56.58 million +1.1%N/A7781 $72.71 2/29/2024769,600 shares $54.09 million +15.3%N/A0 $70.28 2/15/2024667,700 shares $46.93 million +19.9%N/A4.6 $70.28 1/15/2024880,300 shares $29.27 million -14.5%N/A38.8 $33.25 12/31/20231,029,900 shares $42.23 million -9.2%N/A84.5 $41.00 12/15/20231,133,600 shares $42.02 million -43.1%N/A1889.3 $37.07 11/30/20231,991,700 shares $50.91 million +497.8%N/A19917 $25.56 11/15/2023333,200 shares $10.51 million +12.9%N/A1110.7 $31.55 10/31/2023295,200 shares $8.28 million -1.4%N/A2952 $28.06 10/15/2023299,300 shares $9.03 million +1.5%N/A0 $30.18 9/30/2023294,800 shares $8.90 million +0.4%N/A0 $30.18 9/15/2023293,500 shares $8.86 million -1.8%N/A0 $30.18 8/31/2023298,800 shares $9.02 million +3.9%N/A0 $30.18 8/15/2023287,500 shares $8.68 million -13.5%N/A0 $30.18 7/31/2023332,400 shares $10.03 million -19.3%N/A0 $30.18 7/15/2023411,700 shares $12.43 million -6.5%N/A187.1 $30.18 6/30/2023440,200 shares $13.44 million -11.1%N/A550.3 $30.54 6/15/2023495,200 shares $15.06 million -6.2%N/A1650.7 $30.41 5/31/2023528,000 shares $13.55 million +1.1%N/A406.2 $25.66 5/15/2023522,300 shares $10.85 million +0.7%N/A5223 $20.77 4/30/2023518,800 shares $10.20 million 0.0%N/A0 $19.66 4/15/2023518,900 shares $10.20 million +0.5%N/A5189 $19.66 3/31/2023516,600 shares $8.93 million -1.4%N/A0 $17.29 3/15/2023524,100 shares $9.06 million -0.2%N/A748.7 $17.29 2/28/2023524,900 shares $9.89 million +0.2%N/A5249 $18.85 2/15/2023524,000 shares $9.88 million -14.1%N/A5240 $18.85I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 1/31/2023609,800 shares $11.49 million +0.8%N/A6098 $18.85 1/15/2023605,200 shares $10.02 million +0.5%N/A672.4 $16.55 12/30/2022602,300 shares $8.54 million +0.0%N/A2007.7 $14.18 12/15/2022602,200 shares $9.15 million -1.5%N/A0 $15.20 11/30/2022611,600 shares $9.30 million -12.8%N/A6116 $15.20 11/15/2022701,600 shares $14.24 million +2.0%N/A7016 $20.29 10/31/2022688,000 shares $13.96 million +2.4%N/A0 $20.29 10/15/2022672,200 shares $13.64 million -3.7%N/A6722 $20.29 9/30/2022697,900 shares $14.10 million +2.9%N/A6979 $20.21 9/15/2022678,100 shares $11.02 million +0.6%N/A3390.5 $16.25 8/31/2022674,300 shares $12.42 million -12.0%N/A6743 $18.42 8/15/2022766,400 shares $16.96 million -4.3%N/A7664 $22.13 7/31/2022800,600 shares $17.72 million -0.5%N/A8006 $22.13 7/15/2022804,900 shares $16.48 million +0.8%N/A8049 $20.48 6/30/2022798,200 shares $16.15 million +3.9%N/A7982 $20.23 6/15/2022768,200 shares $14.73 million +1.2%N/A7682 $19.17 5/31/2022759,300 shares $16.02 million -9.6%N/A1518.6 $21.10 5/15/2022840,100 shares $16.24 million +0.9%N/A8401 $19.33 4/30/2022832,300 shares $17.79 million +0.3%N/A8323 $21.38 4/15/2022829,900 shares $21.56 million -2.0%N/A8299 $25.98 3/31/2022847,000 shares $22.70 million +12.0%N/A8470 $26.80 3/15/2022756,500 shares $20.48 million -6.1%N/A7565 $27.07 2/28/2022806,000 shares $21.82 million +1.6%N/A8060 $27.07 2/15/2022793,600 shares $24.51 million +0.7%N/A0 $30.88 1/31/2022788,000 shares $24.33 million +17.3%N/A1313.3 $30.88 1/15/2022672,000 shares $24.96 million -10.8%N/A0 $37.15 12/31/2021752,900 shares $27.97 million +3.5%N/A7529 $37.15 12/15/2021727,200 shares $26.61 million -4.8%N/A7272 $36.60 11/30/2021764,200 shares $29.21 million +1.2%N/A3821 $38.22 11/15/2021755,300 shares $32.93 million +8.0%N/A3776.5 $43.60 10/29/2021699,300 shares $30.48 million +9.2%N/A6993 $43.59 10/15/2021640,500 shares $29.42 million +23.3%N/A6405 $45.94 9/30/2021519,300 shares $24.85 million +17.6%N/A5193 $47.86 9/15/2021441,600 shares $21.73 million +1.3%N/A4416 $49.20 8/31/2021436,000 shares $22.50 million -8.6%N/A4360 $51.60 8/13/2021477,000 shares $24.61 million +21.6%N/A4770 $51.60 7/30/2021392,300 shares $33.25 million -18.9%N/A230.8 $84.75 7/15/2021483,400 shares $40.97 million +6.7%N/A4834 $84.75 6/30/2021453,200 shares $38.41 million +34.0%N/A4532 $84.75 6/15/2021338,300 shares $28.67 million +24.2%N/A3383 $84.75 5/28/2021272,300 shares $23.42 million -14.3%N/A2723 $86.00 5/14/2021317,600 shares $29.55 million -11.3%N/A3176 $93.05 4/30/2021358,100 shares $33.32 million -0.3%N/A3581 $93.05 4/15/2021359,000 shares $32.49 million +1.1%N/A3590 $90.50 3/31/2021355,100 shares $35.49 million +3.6%N/A0 $99.95 3/15/2021342,900 shares $0.00 +8.6%N/A87.9 $0.00 2/26/2021315,800 shares $31.56 million +4.6%N/A3158 $99.95 2/12/2021301,900 shares $0.00 -21.9%N/A3019 $0.00 1/29/2021386,400 shares $0.00 -18.2%N/A3864 $0.00 1/15/2021417,200 shares $0.00 -5.9%N/A0 $0.00I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 12/31/2020444,300 shares $0.00 +6.5%N/A493.7 $0.00 MPSYF Short Interest - Frequently Asked Questions What is MorphoSys' current short interest? Short interest is the volume of MorphoSys shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 5,000 shares of MPSYF short. Learn More on MorphoSys' current short interest. What is a good short interest ratio for MorphoSys? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MPSYF shares currently have a short interest ratio of 50.0. Learn More on MorphoSys's short interest ratio. How does MorphoSys' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to MorphoSys: Alvotech (0.08%), Basilea Pharmaceutica AG (0.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short MorphoSys stock? Short selling MPSYF is an investing strategy that aims to generate trading profit from MorphoSys as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against MorphoSys? A short squeeze for MorphoSys occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MPSYF, which in turn drives the price of the stock up even further. How often is MorphoSys' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MPSYF, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies ATNFW Short Interest Data FFNTF Short Interest Data AGTX Short Interest Data AGNPF Short Interest Data ALST Short Interest Data ALVOW Short Interest Data ALVO Short Interest Data HIPH Short Interest Data ANTH Short Interest Data AZNCF Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MPSYF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MorphoSys AG Please log in to your account or sign up in order to add this asset to your watchlist. Share MorphoSys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.